KospicyKorean filings in English
Filings / Prestige Biologics Co., Ltd.

Beneficial Ownership Report (5%) — Standard Form

Prestige Biologics Co., Ltd. · 주식등의대량보유상황보고서(일반)

SC 13D/GKOSDAQ · 334970 Filed 2026-11-09Korean original on DART

English form view 76% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Report on large shareholdings (general)

6.1

프레스티지바이오로직스(주)

0000

Report on Large Holdings of Shares, etc.

(General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control)
To: Financial Services CommissionReporting obligation date:2026-11-04
To: Korea ExchangeReport reference date:2026-11-09
Reporting person:프레스티지바이오파마
Summary
Issuer name프레스티지바이오로직스(주)Relationship to IssuerLargest Shareholder
Report TypeChange
Number of Shares Held and Holding RatioNumber of Shares HeldHolding Ratio
Previous Report46,936,09960.37
Current Report46,901,69960.32
Shares under key agreements: number and ratioNumber of shares, etc.Ratio
Previous Report--
Current Report--
Number of voting rights and holding ratioNumber of Voting RightsHolding Ratio
Previous Report--
Current Report--
Voting rights under key agreements: number and ratioNumber of Voting RightsRatio
Previous Report--
Current Report--
Reason for Report특별관계자 보유주식 변동
※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission.

Part 1 Report Overview

1. Issuer information

Company Name프레스티지바이오로직스(주)Company code334970
Entity typeKOSDAQ-Listed CompanyTotal Issued Voting Shares (shares)77,752,637

발행회사의 의결권있는 발행주식 총수는 당사의 유상증자대금 납입 완료에 따라 증가된 주식총수를 반영한 수치입니다.

2. Major shareholder information

a. Reporting person

(1) Reporting person overview

Report TypeChangeJoint signatories
Reporting person typeForeign CorporationNationalitySingapore
Basis for Reporter Classification (only if reported as a statutory partnership or other entity)-
Name (Entity Name)Korean프레스티지바이오파마Chinese characters (English)Prestige Biopharma Limited
Address (Head Office) [Town/District Level Only]#04-24 Nucleos South Building,Singapore 138567Date of Birth or Business Registration No., etc.49190
Occupation (business)의약품 제조업Relationship to IssuerLargest Shareholder
Business contact and person in chargeAffiliated company프레스티지바이오파마Department경영지원실
PositionGeneral ManagerPhone Number051-58**
Name김민주Fax number051-20**
Email address**[email protected]

(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)

(단위 : USD)
Legal formCo., Ltd.
Total Assets (or Total Assets Under Management)478,545,810Total Liabilities151,334,608
Total Equity327,211,202Paid-in Capital525,727,248
Representative (representative or managing partner)박소연
Decision-Making Body (Decision Maker)이사회, 주주총회
Largest Shareholder (Largest Investor)Mayson Partners Pte.LtdLargest Shareholder Ownership (%) (Largest Investor Contribution Ratio)21.65

주) 프레스티지바이오파마의 결산기는 6월이며, 상기 재무정보는 2026-06-30 연결 재무제표 기준입니다. 【 보고자의 최대주주가 법인, 기타단체, 법령상조합, 민법상 조합의 경우】* 법인명 : Mayson Parters Pte. Ltd

(단위 : SGD)
Legal form유한회사(해외 투자목적회사)
Total Assets (or Total Assets Under Management)78,553,113Total Liabilities7,595,451
Total Equity70,939,662Paid-in Capital100
Representative (representative or managing partner)박소연
Decision-Making Body (Decision Maker)이사회, 주주총회
Largest Shareholder (Largest Investor)박소연Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)50

주) Mayson Partners Pte. Ltd의 결산기는 6월이며, 상기 재무정보는 2026-06-30 기준입니다.

b. Specially related parties

(1) Specially related party overview

No.NameCategorySpecific Relationship to ReporterDate of Birth or Business Registration No., etc.NationalityAddress (Location)Occupation (Business)Relationship to Issuer
1박소연Individual (Domestic)CEO630115Republic of Korea부산광역시 강서구 명지2동ExecutiveOfficers of affiliates, etc.
2김진우개인(외국)Executive640608United States서울특별시 서초구 반포대로ExecutiveOfficers of affiliates, etc.
3임영수Individual (Domestic)Officer of Affiliate630315Republic of Korea서울특별시 동작구 흑석동Officer of IssuerExecutive officers (registered)
4동현철Individual (Domestic)Other610529Republic of Korea서울특별시 용산구 이촌동--
5박천수Individual (Domestic)Other690912Republic of Korea서울특별시 강남구 도곡동--
* Address to town/district level only

(2) Details of specially related parties (for corporations, other entities, statutory or civil-law partnerships)

Legal form-
Total Assets (or Total Assets Under Management)-Total Liabilities-
Total Equity-Paid-in Capital-
Representative (representative or managing partner)-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Largest Investor)-Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)-

c. Collective investment manager

(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))

(1) Collective investment manager overview

No.NameBusiness Registration No., etc.Target collective investment vehicleNationalityAddress (Location)Remarks
-------

(2) Collective investment manager details

Legal form-
Paid-in Capital-Total Assets Under Management-
Representative-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Corporate Representative)-Largest Shareholder Stake-

3. Shares, etc. held and holding ratio

Report reference dateReporting personShares, etc.Share CertificatesTotal Issued Voting Shares (shares)
Name of HolderNumber of Specially Related PersonsNumber of Shares, etc. (shares)Ratio (%)Number of Shares (shares)Ratio (%)
Previous Report2026-07-10프레스티지바이오파마546,936,09960.3746,936,09960.3777,752,637
This Report2026-11-09프레스티지바이오파마346,901,69960.3246,901,69960.3277,752,637
Change-34,400-0.05-34,400-0.050

4. Purpose of holding

Impact on management control
Ⅰ. 이사 및 감사의 선임ㆍ해임 또는 직무의 정지Ⅱ. 이사 및 이사회 등 회사의 기관과 관련된 정관의 변경Ⅲ. 회사의 자본금의 변경Ⅳ. 회사의 배당 결정에 대한 영향Ⅴ. 회사의 합병(간이합병 및 소규모합병을 포함한다) 및 분할Ⅵ. 주식의 포괄적 교환 및 이전Ⅶ. 영업의 전부 또는 중요한 일부의 양수 또는 양도Ⅷ. 자산의 전부 또는 중요한 일부의 처분 또는 양도Ⅸ. 영업의 전부 또는 중요한 일부의 임대, 경영 위임 또는 타인과 영업의 손익 전부를 같이 하는 계약 기타 이에 준하는 계약의 체결, 변경 또는 해약Ⅹ. 회사의 해산보고자는 상위 Ⅰ∼Ⅹ 각 호 사항에 대하여 회사의 최대주주로서 회사에 영향력을 행사 할 수도 있습니다. 현재 Ⅰ∼Ⅹ 각 호의 사항에 대한 구체적인 계획은 없지만, 회사의 업무집행과 관련한 상위 사항이 발생할 경우에는 회사의 경영목적에 부합하도록 관련 행위들을 결정할 예정입니다.

5. Reason for change

Method of change장내매수 / 장외매수
Reason for change특별관계자 장내매수 및 장외매수에 따른 보유주식수 변동
Reason for Change-

Part 2 Details of Large Holdings

1. Holdings by reporting person and specially related persons

A. Holdings by type of shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Shares Held
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person프레스티지바이오파마4919031,122,728--------31,122,72840.03
Specially Related Party박소연6301157,807,821--------7,807,82110.04
김진우6406087,815,201--------7,815,20110.05
임영수630315155,949--------155,9490.20
동현철610529-----------
박천수690912-----------
Aa1a2BCDEFG
H
Total Issued Voting Shares (I)Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H)Holding Ratio (%)
Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100Share Holding Ratio (A / I) × 100
77,752,637-60.3260.32

※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares

B. Holdings by form of holding

RelationshipName (Entity Name)Date of Birth or Business Registration No., etc.Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act)Total
No. 1No. 2No. 3No. 4No. 5No. 6No. 7Number of sharesRatio
Reporting person프레스티지바이오파마4919031,122,728------31,122,72840.03
Specially Related Party박소연6301157,807,821------7,807,82110.04
김진우6406087,815,201------7,815,20110.05
임영수630315155,949------155,9490.20
동현철610529---------
박천수690912---------
※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them

2. Contracts on shares held

A. Contract status

Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.)
None

*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported

B. Contract details

No.Name (Entity Name)Relationship to ReporterDate of Birth or Business Registration No., etc.Type of shares, etc.Number of shares, etc.CounterpartyContract typeContract date (amendment date)Contract periodRatioRemarks
------------
Total (number of shares, etc.)-Total (ratio)--

C. Additional details if the main contract is a security agreement

No.Number of shares, etc.Loan amountDebtorInterest rateCollateral maintenance ratioOther
-------

3. Holdings by proprietary and customer account (financial institutions only)

NameRelationship to ReporterBy accountTotal
Own Account (shares)Ratio (%)Customer account (shares)Ratio (%)Total (shares)Ratio (%)
--------
Total------

Part 3 Material Changes Since Last Report Date

1. Summary of changes

a. Changes in shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Changes in Shares, etc.
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person프레스티지바이오파마49190-----------
Specially Related Party박소연630115-----------
김진우640608-----------
임영수630315137,500--------137,5000.17
동현철610529-80,000---------80,000-0.10
박천수690912-91,900---------91,900-0.12

2. Change details

a. Detailed changes in shares, etc.

(Unit: shares, KRW)
Name (Entity Name)Date of Birth or Business Registration No., etc.Change Date*Acquisition/disposal methodType of shares, etc.Change detailsAcquisition/disposal unit price**Remarks
Before ChangeChangeAfter Change
동현철6105292026.11.02임원퇴임(-)Voting Shares80,000-80,0000---
박천수6909122026.11.02임원퇴임(-)Voting Shares91,900-91,9000---
임영수6303152026.11.02On-Market Purchase (+)Voting Shares18,44929,00047,4491,131--
임영수6303152026.11.03On-Market Purchase (+)Voting Shares47,44939,00086,4491,150--
임영수6303152026.11.04장외매수(+)Voting Shares86,44955,000141,4491,179-동현철
임영수6303152026.11.04On-Market Purchase (+)Voting Shares141,4493,000144,4491,168--
임영수6303152026.11.05On-Market Purchase (+)Voting Shares144,44911,500155,9491,161--

* For trades on the securities market, the contract date

** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities

3. Source of acquisition funds

(1) Overview of acquisition funds

(Unit: KRW)
NameDate of birth or business registration no., etc.Own funds (H)Borrowings (I)Other (J)Total (H+I+J)
임영수630315159,349,500--159,349,500

(2) Origin and source of acquisition funds

ㅇ If own funds

NameDate of birth or business registration no., etc.Source and Formation of Acquisition Funds
임영수630315Own Funds